Express News | Tempus Announces the National Launch of FDA-Approved Xt Cdx Test

Breakings4minutes ago

Tempus Announces the National Launch of FDA-Approved XT CDx Test

Businesswire4minutes ago

Loop Capital Maintains Tempus AI(TEM.US) With Buy Rating, Cuts Target Price to $52

Futu NewsJan 14 21:31 · Ratings

Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care

BusinesswireJan 14 21:30

Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock

BenzingaJan 14 21:00

TEM Stock Declines Following Preliminary Q4 Sales Miss

Zacks Jan 14 20:35